Sorrento Therapeutics Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the rating industry group for Sorrento Therapeutics Inc are shownin the table. If you are employed by Sorrento Therapeutics Inc and you wish to licence your ESG rating, please contact us. This analysis of Sorrento Therapeutics Inc uses data points from across the internet as well as from public filings by Sorrento Therapeutics Inc.
Sorrento Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 1.3, social score of 1.1 and governance score of 4.0.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | Sorrento Therapeutics Inc | 2.1 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sorrento Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sorrento Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Sorrento Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sorrento Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Sorrento Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sorrento Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sorrento Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Sorrento Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sorrento Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sorrento Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sorrento Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sorrento Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sorrento Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sorrento Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Sorrento Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Sorrento Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sorrento Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sorrento Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugates, as well as bispecific antibody approaches; and Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host diseases. The company also develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. In addition, it engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; and SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain conditions. Additionally, the company has various collaborations with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 86 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patients with melanoma; and Karolinska Institutet. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California.